Clinical Trials
43 trialsMultitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
National Institutes of Health Clinical Center (CC)
MOMENT
Prostate Cancer Clinical Trials Consortium
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
Washington University School of Medicine
Radiation Treatment of the Prostate That is Specially Adjusted for Each Person
AHS Cancer Control Alberta
ROBOPREP
Surgical Outcomes Research Centre (SOuRCe)
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation
University of California, Irvine
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Chinese University of Hong Kong
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Cedars-Sinai Medical Center
POSTPONE
Medical College of Wisconsin
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
University of Arkansas
ProCan
Regionshospital Nordjylland
REVIVE
University Health Network, Toronto
MIDAS-SBRT
University Health Network, Toronto
ART-Hypo
Centre hospitalier de l'Université de Montréal (CHUM)
A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer
Sunnybrook Health Sciences Centre
ANDARP
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
University of Washington
TeLuNa
Ankara University
Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy
RenJi Hospital
ARPEGGIO
Brigham and Women's Hospital
SENTRY
University of California, San Diego
Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
The University of Hong Kong
FORWARD
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer
AHS Cancer Control Alberta
Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019
Peking University First Hospital
CONVERT-HB1
Fudan University
Memantine Hydrochloride in Prostate Cancer Patients
Zhongda Hospital
Folate Study in Men With Advanced Prostate Cancer
University of California, San Diego
TOPPGUN-RS
Centre Hospitalier Universitaire de Liege
Cleaning the Biopsy Needle in TRUS Bx
Hitit University
Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients with Intermediate or High Risk Localized Prostate Cancer (ARP)
British Columbia Cancer Agency
The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy
Sun Yat-sen University
Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.
Qilu Hospital of Shandong University
ESTRACISE
Central Finland Hospital District
SChLAP/IDC
University Health Network, Toronto
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
Convalife (Shanghai) Co., Ltd.
HETERERO
Charite University, Berlin, Germany
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
University of Kansas Medical Center
ARES
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CHAMPION
Fudan University
AFFIRM
Radboud University Medical Center
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
James J. Peters Veterans Affairs Medical Center
The Effect of Metformin in Patients With Newly Diagnosed mHSPC
Sun Yat-sen University